Open AccessVemurafenib plus rituximab in relapsed or refractory hairy cell leukemia
Author(s) -
Ajay Gogia,
AnnieKanchan Baa
Publication year - 2022
Publication title -
cancer research, statistics, and treatment/cancer research, statistics and treatment
Language(s) - English
Resource type - Journals
eISSN - 2590-3233
pISSN - 2590-3225
DOI - 10.4103/crst.crst_8_22
Subject(s) - rituximab , vemurafenib , refractory (planetary science) , medicine , leukemia , oncology , cancer research , lymphoma , biology , melanoma , metastatic melanoma , astrobiology